IRVINE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Inc. (Nasdaq: SBC) has announced the approval of a share repurchase program, with the board authorizing a maximum aggregate amount of US $5 million. The repurchase is set to commence on May 20, 2025, and will continue until May 20, 2026, utilizing surplus cash and future free cash flow. The company aims to enhance shareholder value and address what it perceives as an undervaluation of its shares in the market.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。